Medpace Holdings (MEDP) EBIT Margin (2015 - 2026)

Medpace Holdings (MEDP) has reported EBIT Margin for 12 consecutive years, with 20.03% the latest figure, recorded in Q1 2026.

• EBIT Margin for Q1 2026 came in at 20.03%, down 30.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 21.02% (down 14.0% YoY), and the FY2025 annual result was 21.14%, down 5.0% from the prior year.
• EBIT Margin was 20.03% for Q1 2026 at Medpace Holdings, down from 21.63% in the prior quarter.
• Over five years, EBIT Margin peaked at 23.37% in Q4 2024 and troughed at 17.01% in Q2 2023.
• Average EBIT Margin over 5 years is 19.82%, with a median of 20.03% recorded in 2026.
• Year-over-year, EBIT Margin tumbled 304 bps in 2023 and surged 585 bps in 2024.
• Over 5 years, EBIT Margin stood at 19.39% in 2022, then declined by 10 bps to 17.52% in 2023, then jumped by 33 bps to 23.37% in 2024, then decreased by 7 bps to 21.63% in 2025, then dropped by 7 bps to 20.03% in 2026.
• Per Business Quant data, the three most recent EBIT Margin figures were 20.03% in Q1 2026, 21.63% in Q4 2025, and 21.49% in Q3 2025.